EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Long-Term Patency of Hemashield Vascular Grafts Used for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation: A Single-Center Korean Experience

Dae Hyeon Won iD, Shin Hwang iD, Chul-Soo Ahn iD, Deok-Bog Moon iD, Tae-Yong Ha iD, Gi-Won Song iD, Dong-Hwan Jung iD, Gil-Chun Park iD, Woo-Hyoung Kang iD, Young-In Yoon iD, Sung-Gyu Lee iD

Annals of Transplantation · 2026

DOI: 10.12659/aot.951216 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Transplantation, 2026. Verfasst von Dae Hyeon Won und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seo…. Hauptthemen laut MEDLINE: Liver Transplantation, Hepatic Veins, Vascular Patency, Blood Vessel Prosthesis. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The availability of homologous vein allografts is limited. Therefore, prosthetic vascular grafts can be used as alternatives for middle hepatic vein (MHV) reconstruction during living-donor liver transplantation (LDLT). This study evaluated the short- and long-term patency of MHV reconstructions using Hemashield vascular grafts and assessed their effect on post-transplant survival. MATERIAL AND METHODS This retrospective observational study included 149 adult LDLT recipients who underwent MHV reconstruction using Hemashield grafts at a single institution. Graft patency and survival outcomes were assessed over long-term follow-up. RESULTS The mean recipient age was 56.2±7.7 years, and the mean graft-to-recipient weight ratio was 1.06±0.25. V5 reconstruction was achieved through single, double, and triple anastomoses in 111, 32, and 2 patients, respectively. V8 reconstruction in 116, 20, and one patient was achieved through single, double, and triple anastomoses, respectively. In 100 and 49 cases, we used Hemashield grafts with diameters of 10 mm and 12 mm, respectively. Three patients (2.0%) developed early thrombosis that necessitated stent placement. The cumulative conduit occlusion-free survival rates were 81.0% at 3 months, 57.9% at 1 year, 48.7% at 3 years, and 43.8% at 5 years. Overall patient survival rates were 95.3% at 1 year, 89.1% at 3 years, and 85.7% at 5 years. No cases of graft migration or conduit-related infection were identified. CONCLUSIONS MHV reconstruction using Hemashield grafts demonstrated acceptable short- and long-term patency, with no migration or infection. These findings support the use of Hemashield grafts as a reliable and effective prosthetic option for MHV reconstruction during LDLT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHepatic VeinsVascular PatencyBlood Vessel ProsthesisHumansMiddle AgedMaleFemaleRetrospective StudiesLiving DonorsAdultRepublic of KoreaAgedTreatment OutcomeGraft Survival

Autor:innen und Institutionen

  • Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

ORCID-Profile: Dae Hyeon Won, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Woo-Hyoung Kang, Young-In Yoon, Sung-Gyu Lee

Zitieren

APA

Won, D. H., Hwang, S., Ahn, C. S., Moon, D. B., Ha, T. Y., Song, G. W., Jung, D. H., Park, G. C., Kang, W. H., Yoon, Y. I., & Lee, S. G. (2026). Long-Term Patency of Hemashield Vascular Grafts Used for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation: A Single-Center Korean Experience. Annals of Transplantation. https://doi.org/10.12659/aot.951216

Vancouver

Won DH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, et al. Long-Term Patency of Hemashield Vascular Grafts Used for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation: A Single-Center Korean Experience. Annals of Transplantation. 2026. doi:10.12659/aot.951216

BibTeX
@article{Won2026,
  author = {Won, Dae Hyeon and Hwang, Shin and Ahn, Chul-Soo and Moon, Deok-Bog and Ha, Tae-Yong and Song, Gi-Won and Jung, Dong-Hwan and Park, Gil-Chun and Kang, Woo-Hyoung and Yoon, Young-In and Lee, Sung-Gyu},
  title = {Long-Term Patency of Hemashield Vascular Grafts Used for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation: A Single-Center Korean Experience},
  journal = {Annals of Transplantation},
  year = {2026},
  doi = {10.12659/aot.951216}
}
Kostenlos starten →